Sector portfolio · Private equity · United States

General Atlantic's Biotech portfolio

General Atlantic has backed 20 Biotech startups in rounds we track, $4.7B between them, shown by the stage each has reached. The best-funded is Verdiva Bio.

20startups backed
4stages
$4.7Braised between them
Stage not reportedbiggest stage

General Atlantic's whole portfolioGeneral Atlantic's profile

Segment by segment

Stage not reported

7 startups · $1.7B raised

  1. Ultima GenomicsUltima Genomics, Inc.United States$600M
  2. AlumisAlumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.United States$345M
  3. Nurix TherapeuticsNurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.United States$250M
  4. Centessa PharmaceuticalsCentessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.United States$250M
  5. OTOcumension TherapeuticsOcumension Therapeutics is a pharmaceutical platform dedicated to identifying, developing, and commercializing ophthalmic therapies.China$164M
  6. RRRubicon ResearchIndia$100M
  7. Third Harmonic BioThird Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.United States$3.9M

Series C and later

6 startups · $1.1B raised

  1. PathAIPathAI develops technology that assists pathologists in making accurate diagnoses for every patient, every time.United States$400M
  2. GBGingko BioworksUnited States$275M
  3. SonendoSonendo is a healthcare company that focuses on developing innovative and disruptive technologies to transform endodontic therapy.United States$146M
  4. BiotheusBiotheus is a biotech company that focuses on the discovery and development of antibody-based therapeutics.China$115M
  5. AdageneAdagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies.China$83M
  6. BiofourmisBiofourmis is a global technology-enabled care delivery provider based in Boston, Massachusetts, with additional offices in SingapUnited States$55M

Series A

4 startups · $1.0B raised

  1. Verdiva BioVerdiva Bio is a clinical-stage biopharmaceutical company based in Guildford, United Kingdom, founded in 2024.United Kingdom$601M
  2. CPCinCor PharmaCinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.United States$275M
  3. LifeCareLifeCare is a privately held company based in Shelton, Connecticut, specializing in employer-sponsored work-life benefits and care solutions.United States$105M
  4. AllonniaAllonnia is a Boston-based bio-ingenuity company founded in 2019, focusing on environmental biotechnology and engineering.United States$20M

Series B

3 startups · $914M raised

  1. Akero TherapeuticsAkero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.United States$502M
  2. Expedition TherapeuticsExpedition Therapeutics is a biotechnology company based in San Francisco, founded in 2024.United States$280M
  3. PharvarisPharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.Switzerland$132M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names General Atlantic as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios

Raising from investors like General Atlantic?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.